Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › GLP-1/glucagon receptor co-agonists for medical use

GLP-1/glucagon receptor co-agonists for medical use

US Patent 10570184 · Granted Feb 25, 2020

Estimated economic value: $61,802,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Glucose-sensitive albumin-binding derivatives2025
Amylin receptor agonists2024
Amylin receptor agonists2024
Co-agonists of the GLP-1 and amylin receptors2024
Glucose-sensitive albumin-binding derivatives2023
Compounds for treatment of obesity2023
GIP derivatives and uses thereof2023
Glucose sensitive insulins and uses thereof2023
Double-acylated GLP-1 derivatives2022
Glucose-sensitive albumin-binding derivatives2021
Double-acylated GLP-1 derivatives2021
Double-acylated GLP-1 derivatives2021